Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
2020 · Nature Communications · 161 citations
https://doi.org/10.1038/s41467-020-17175-8
C
Christopher DeRenzo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
1.5K
Citations
18
h-index
24
i10-index
Christopher DeRenzo is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Viral Infectious Diseases and Gene Expression in Insects. The author has an h-index of 18, co-authored 99 publications.
ORCID: 0000-0001-6127-4601Papers by this author
worksEpigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
2024 · Science · 71 citations
https://doi.org/10.1126/science.adl4492
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
2024 · Nature Cancer · 70 citations
https://doi.org/10.1038/s43018-024-00749-6
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells
2020 · Molecular Therapy — Oncolytics · 62 citations
https://doi.org/10.1016/j.omto.2020.06.018
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives
2024 · EJC Paediatric Oncology · 14 citations
https://doi.org/10.1016/j.ejcped.2024.100160
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
2024 · Cell Reports Medicine · 11 citations
https://doi.org/10.1016/j.xcrm.2024.101469
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat